Loading clinical trials...

The Impact of Pediatric Skin Disorders: The "Big" Study | Clinical Trials | Clareo Health

COMPLETED

The Impact of Pediatric Skin Disorders: The "Big" Study

NCT03544866•Northwestern University

Summary

This study leverages the availability of a validated series of instruments to measure the effect of highly visible, chronic skin disorders, including atopic dermatitis (AD), on patients 8 years of age and above in causing stigma and psychiatric issues, particularly anxiety and depression.

Detailed Description

This is a multi center study with Northwestern University/Lurie Children's Hospital serving as the Data Coordinating Center. Site selection has been completed through members of PeDRA.

Eligibility

Age

8 - 17 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Subjects must be aged 8-17 years of age
•Subject must be diagnosed with a chronic skin disease deemed to be severe enough and/or in a visible location that could be stigmatizing as determined by the study doctor
•Subject and parent must both be English speaking with at least one parent/guardian who will complete the questionnaires
•Subject and Parent/Guardian must be able to complete the relevant questionnaires

Exclusion Criteria

•Children under 8 years of age
•Children with developmental delay and/or a behavioral disorder that would preclude participation in form completion
•Children with a non-cutaneous disorder that is considered by the Study doctor to be stigmatizing

Locations (1)

Department of Dermatology, Northwestern University Feinberg School of Medicine and Lurie Children's Hospital

Chicago, Illinois, United States

Key Dates

Start Date

November 16, 2018

Primary Completion Date

May 31, 2021

Completion Date

January 31, 2022

Last Updated

April 6, 2022

Enrollment

1,666

ACTUAL participants

Conditions

Chronic Pediatric Skin Conditions